Lapo Alinari
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Dermatology top 1%
- Cutaneous lymphoproliferative disorders research
Papers in
-
- Lymphoma Diagnosis and Treatment 81
- Oncology 52
- Viral-associated cancers and disorders 19
- CAR-T cell therapy research 16
- Co-authors
- Pier Luigi Zinzani (41 shared papers)Monica Tani (34 shared papers)Vittorio Stefoni (33 shared papers)Robert A. Baiocchi (53 shared papers)Michele Baccarani (28 shared papers)Enrica Marchi (21 shared papers)Gerardo Musuraca (19 shared papers)Stefano Pileri (18 shared papers)
- Journals
- Blood (33 papers)Blood Advances (5 papers)Journal of Clinical Oncology (5 papers)Cancer (4 papers)PLoS ONE (3 papers)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Lapo Alinari
108 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 82
- Pathology and Forensic Medicine 1.7k
- Dermatology 442
- Genetics 491
- Neurology 463
- Oncology 793
Countries citing papers authored by Lapo Alinari
This map shows the geographic impact of Lapo Alinari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lapo Alinari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lapo Alinari more than expected).
Fields of papers citing papers by Lapo Alinari
This network shows the impact of papers produced by Lapo Alinari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lapo Alinari. The network helps show where Lapo Alinari may publish in the future.
Co-authors
The 25 scholars most cited alongside Lapo Alinari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 204 | |
| 2 | 2006 | 143 | |
| 3 | 2015 | 131 | |
| 4 | 2009 | 108 | |
| 5 | 2006 | 106 | |
| 6 | 2005 | 106 | |
| 7 | 2010 | 88 | |
| 8 | 2007 | 84 | |
| 9 | 2004 | 81 | |
| 10 | Primary bone lymphoma: experience with 52 patients. | 2003 | 76 |
| 11 | 2005 | 74 | |
| 12 | 2011 | 66 | |
| 13 | 2004 | 62 | |
| 14 | Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. | 2005 | 61 |
| 15 | 2008 | 58 | |
| 16 | 2007 | 57 | |
| 17 | 2009 | 56 | |
| 18 | 2005 | 51 | |
| 19 | Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine. | 2004 | 50 |
| 20 | 2008 | 49 |
About Lapo Alinari
Lapo Alinari is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 115 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (81 papers), Chronic Lymphocytic Leukemia Research (34 papers), Viral-associated cancers and disorders (19 papers), Cancer-related gene regulation (17 papers), CAR-T cell therapy research (16 papers), CNS Lymphoma Diagnosis and Treatment (13 papers), Medical Imaging Techniques and Applications (11 papers) and Cutaneous lymphoproliferative disorders research (9 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.7k citations), Dermatology (442 citations), Genetics (491 citations), Neurology (463 citations) and Oncology (793 citations). Lapo Alinari has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Pier Luigi Zinzani, Monica Tani, Vittorio Stefoni, Robert A. Baiocchi, Michele Baccarani, Enrica Marchi, Gerardo Musuraca, Stefano Pileri, Paolo Castellucci and Mariapaola Fina. Their work appears in journals such as Blood, Blood Advances, Journal of Clinical Oncology, Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.